[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-mirum-pharmaceuticals-stock-drops-15-after-share-offering-analysts-still-target-120-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":341},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},94816,"Les actions de Mirum Pharmaceuticals chutent de 15 % après l'offre d'actions. Les analystes visent toujours 120 $.","2026-02-27T16:15:00","2026-02-27T15:33:08","\u003Cp>Voici pourquoi l'action de Mirum Pharmaceuticals a chuté de 15 % après l'annonce d'une offre secondaire d'actions, malgré une forte croissance des ventes en 2025.\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-mirm-stock\">\u003Cstrong>Principales statistiques\u003C\u002Fstrong> pour l'\u003Cstrong>action\u003Cstrong>MIRM\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Variation du prix de l'action \u003Cstrong>MIRM\u003C\u002Fstrong>:\u003C\u002Fstrong> -15%.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>MIRM\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Cours de l'action au 26 \u003Cstrong>février \u003C\u002Fstrong>:\u003C\u002Fstrong> 92\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Plus haut sur 52 semaines :\u003C\u002Fstrong> 109\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>MIRM\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Objectif de cours : \u003C\u002Fstrong> 120\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">En direct : Découvrez le potentiel de hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">>>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Que s'est-il passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Mirum Pharmaceuticals (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">MIRM\u003C\u002Fa>\u003C\u002Fstrong>) a chuté de 15,1 % le 26 février 2026. Les actions ont clôturé à 92 $ après que la société ait publié ses résultats du quatrième trimestre et annoncé une offre d'actions. La baisse a suivi l'annonce que les actionnaires vendeurs pourraient offrir jusqu'à 8,96 millions d'actions.\u003C\u002Fp>\n\n\n\n\u003Cp>En ce qui concerne les résultats, les ventes nettes de produits au quatrième trimestre ont augmenté de 49,8 % pour atteindre 148,9 millions de dollars, selon Reuters. La société a également indiqué que les ventes de 2025 ont augmenté d'une année sur l'autre. Cependant, le surnombre d'actions a mis l'action sous pression.\u003C\u002Fp>\n\n\n\n\u003Cp>Mirum avait précédemment prévu des ventes nettes mondiales de produits pour 2026 allant jusqu'à 650 millions de dollars. Les investisseurs semblent se concentrer sur la dilution potentielle plutôt que sur la dynamique commerciale. En conséquence, les actions ont fortement reculé par rapport à leurs récents sommets.\u003C\u002Fp>\n\n\n\n\u003Cp>Malgré cette baisse, l'action reste bien au-dessus de son plus bas niveau sur 52 semaines (37 $), mais le sentiment à court terme a changé après l'annonce de l'offre.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1126\" height=\"562\" data-public-id=\"images\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1126,h_562,c_scale\u002Ff_webp,q_auto\u002Fv1772202553\u002Fimages\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp?_i=AA\" alt=\"\" class=\"wp-post-94816 wp-image-94818\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772202553\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772202553\u002Fimages\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp?_i=AA 1126w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_150,c_scale\u002Ff_webp,q_auto\u002Fv1772202553\u002Fimages\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1772202553\u002Fimages\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_383,c_scale\u002Ff_webp,q_auto\u002Fv1772202553\u002Fimages\u002FMIRM-Street-Targets\u002FMIRM-Street-Targets.webp?_i=AA 768w\" sizes=\"auto, (max-width: 1126px) 100vw, 1126px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Objectifs de cours de l'action MIRM\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action MIRM (C'est gratuit !) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-market-is-telling-us-about-mirm-stock\">Ce que le marché nous dit à propos de l'action MIRM\u003C\u002Fh2>\n\n\n\n\u003Cp>Mirum Pharmaceuticals est une société de biotechnologie spécialisée dans les maladies rares du foie. Son produit phare, LIVMARLI, est approuvé pour le prurit cholestatique dans le syndrome d'Alagille. La société commercialise également Cholbam et Chenodal.\u003C\u002Fp>\n\n\n\n\u003Cp>Du point de vue du bilan, Mirum dispose d'une position de trésorerie nette. La dette nette à long terme est négative de 63,9 millions de dollars, et la dette nette par rapport à l'EBITDA est de -14,2x. La valeur de l'entreprise est de 5,5 milliards de dollars, contre une capitalisation boursière de 5,6 milliards de dollars.\u003C\u002Fp>\n\n\n\n\u003Cp>Le bêta de l'action sur 5 ans est de 0,50, ce qui indique une volatilité plus faible que celle de nombreuses sociétés biotechnologiques comparables. Toutefois, les offres secondaires peuvent déclencher des mouvements brusques. Les investisseurs réévaluent souvent l'évaluation lorsque l'offre augmente.\u003C\u002Fp>\n\n\n\n\u003Cp>Mirum a récemment conclu l'acquisition de Bluejay Therapeutics. La société a également reçu l'autorisation de Santé Canada pour LIVMARLI dans le PFIC et le syndrome d'Alagille plus tôt cette année. Ces développements soutiennent l'expansion du pipeline.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une entreprise (gratuit avec TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-mirum-pharmaceuticals-inc\">Devriez-vous investir dans Mirum Pharmaceuticals, Inc.\u003C\u002Fh2>\n\n\n\n\u003Cp>La seule façon de le savoir est d'examiner les chiffres vous-même. TIKR vous donne un accès gratuit aux mêmes \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cmark style=\"background-color:rgba(0, 0, 0, 0);color:#666666\" class=\"has-inline-color\">données financières de qualité institutionnelle\u003C\u002Fmark>\u003C\u002Fa>\u003C\u002Fstrong> que les analystes professionnels utilisent pour répondre exactement à cette question.\u003C\u002Fp>\n\n\n\n\u003Cp>Sélectionnez MIRM et vous verrez des années de données financières historiques, les prévisions des analystes de Wall Street en matière de revenus et de bénéfices pour les trimestres à venir, l'évolution des multiples d'évaluation au fil du temps et la tendance à la hausse ou à la baisse des objectifs de prix.\u003C\u002Fp>\n\n\n\n\u003Cp>Vous pouvez \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cmark style=\"background-color:rgba(0, 0, 0, 0);color:#666666\" class=\"has-inline-color\">\u003Cstrong>créer une liste de surveillance gratuite pour suivre MIRM\u003C\u002Fstrong>\u003C\u002Fmark>\u003C\u002Fa> ainsi que toutes les autres actions sur votre radar. Aucune carte de crédit n'est requise. Juste les données dont vous avez besoin pour décider par vous-même.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003Cstrong>Analyser l'action Mirum Pharmaceuticals\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong> \u003Cstrong>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>sur TIKR \u003Cstrong>Free→\u003C\u002Fstrong> \u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Voyez quelles actions\u003Cstrong> \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n",584,"fr","\u002Fblog\u002Fmirum-pharmaceuticals-stock-drops-15-after-share-offering-analysts-still-target-120","mirum-pharmaceuticals-stock-drops-15-after-share-offering-analysts-still-target-120","images\u002FMIRM-stock\u002FMIRM-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772206228\u002Fimages\u002FMIRM-stock\u002FMIRM-stock.png?_i=AA",{"altText":237,"imageCredit":238},"Mirum Pharmaceuticals Stock Drops 15% After Share Offering. Analysts Still Target $120","dr322 from Getty Images via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Rexielyn Diaz","rexietikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Here’s why Mirum Pharmaceuticals stock fell 15% after announcing a secondary share offering despite strong 2025 sales growth.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","5 minutes",1200,630,[266,281,298,311,326],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"FS L'action de KKR Capital chute de 15% après les résultats du quatrième trimestre. Les actions peuvent-elles rebondir vers 17 $ ?","2026-02-27 16:10:00","Voici pourquoi l'action FS KKR Capital a chuté de 15 % après que les résultats du quatrième trimestre ont montré une baisse du revenu net d'investissement et une chute de la valeur nette d'inventaire.",567,"\u002Fblog\u002Ffs-kkr-capital-stock-drops-15-after-q4-results-can-shares-rebound-toward-17","fs-kkr-capital-stock-drops-15-after-q4-results-can-shares-rebound-toward-17","images\u002FFSK-stock_9483665ddc\u002FFSK-stock_9483665ddc","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772206059\u002Fimages\u002FFSK-stock_9483665ddc\u002FFSK-stock_9483665ddc.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":295,"relatedPosts":297},"Under Armour : Voici pourquoi Wall Street détient 17 positions malgré son trimestre le plus encourageant depuis des années","2026-02-27 16:00:00","Under Armour vient de battre ses résultats et de relever ses prévisions, mais c'est lors de la conférence de presse sur les résultats de mai que le véritable verdict tombera, car la stabilisation de l'exercice 2027, le redressement du prix des chaussures et la dynamique des commandes de gros confirmeront ou annuleront l'ensemble de la stratégie haussière.",903,"\u002Fblog\u002Funder-armour-heres-why-wall-street-has-17-holds-despite-its-most-encouraging-quarter-in-years","under-armour-heres-why-wall-street-has-17-holds-despite-its-most-encouraging-quarter-in-years","images\u002FFEATURED-IMAGE-MAKER-341\u002FFEATURED-IMAGE-MAKER-341","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772159856\u002Fimages\u002FFEATURED-IMAGE-MAKER-341\u002FFEATURED-IMAGE-MAKER-341.png?_i=AA",{"altText":282},{"name":292,"slug":293,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":294},"Gian Estrada","giantikr",[],[296],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":299,"date":283,"excerpt":300,"wordCount":270,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":308,"relatedPosts":310},"L'action Chemed chute de 15 % après l'échec des résultats. Les analystes voient encore une hausse à 556 $.","Voici pourquoi l'action Chemed a chuté de 15 % après avoir manqué les estimations de bénéfices pour le quatrième trimestre, malgré de solides indicateurs de rentabilité à long terme.","\u002Fblog\u002Fchemed-stock-slides-15-after-earnings-miss-analysts-still-see-upside-to-556","chemed-stock-slides-15-after-earnings-miss-analysts-still-see-upside-to-556","images\u002FCHE-stock_94834bda2d\u002FCHE-stock_94834bda2d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772205930\u002Fimages\u002FCHE-stock_94834bda2d\u002FCHE-stock_94834bda2d.png?_i=AA",{"altText":299},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":307},[],[309],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":312,"date":313,"excerpt":314,"wordCount":315,"uri":316,"slug":317,"cloudinaryAssetId":318,"featuredImageOriginalUrl":319,"featuredImageMetadata":320,"author":321,"categories":323,"relatedPosts":325},"L'action de Shift4 Payments chute de 16% après les résultats. Les actions peuvent-elles rebondir vers 88 $ ?","2026-02-27 15:55:00","Voici pourquoi l'action de Shift4 Payments a chuté de 16 % après la publication des résultats, même si les analystes maintiennent des objectifs de prix bien supérieurs à 88 $.",570,"\u002Fblog\u002Fshift4-payments-stock-drops-16-after-earnings-can-shares-rebound-toward-88","shift4-payments-stock-drops-16-after-earnings-can-shares-rebound-toward-88","images\u002FFOUR-stock\u002FFOUR-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772205776\u002Fimages\u002FFOUR-stock\u002FFOUR-stock.png?_i=AA",{"altText":312},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":322},[],[324],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":327,"date":328,"excerpt":329,"wordCount":330,"uri":331,"slug":332,"cloudinaryAssetId":333,"featuredImageOriginalUrl":334,"featuredImageMetadata":335,"author":336,"categories":338,"relatedPosts":340},"L'action d'Eos Energy chute de 39 % en une journée. Voici les raisons de cette chute","2026-02-27 15:50:00","Voici pourquoi l'action Eos Energy a plongé de 39 % après la publication de ses résultats du quatrième trimestre, même si les analystes maintiennent un objectif de prix de 16 $.",604,"\u002Fblog\u002Feos-energy-stock-tumbles-39-in-a-day-heres-whats-driving-the-sell-off","eos-energy-stock-tumbles-39-in-a-day-heres-whats-driving-the-sell-off","images\u002FEOSE-stock\u002FEOSE-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772205391\u002Fimages\u002FEOSE-stock\u002FEOSE-stock.png?_i=AA",{"altText":327},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":337},[],[339],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[342,362,377,392,407,422,442,457,472,487],{"id":255,"title":343,"date":344,"excerpt":345,"wordCount":346,"uri":347,"slug":348,"cloudinaryAssetId":349,"featuredImageOriginalUrl":350,"featuredImageMetadata":351,"author":352,"categories":356,"relatedPosts":361},"L'action de SPX Technologies bondit de 57 % en un an : Voici où l'action pourrait aller en 2026","2026-02-27 15:20:00","Les actions de SPX Technologies (SPXC) se consolident après une année exceptionnelle, alors que la direction utilise son bilan pour dominer le marché du refroidissement des centres de données. ",905,"\u002Fblog\u002Fspx-technologies-stock-surges-57-in-one-year-heres-where-the-stock-could-go-in-2026","spx-technologies-stock-surges-57-in-one-year-heres-where-the-stock-could-go-in-2026","images\u002F14-5\u002F14-5","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772147837\u002Fimages\u002F14-5\u002F14-5.png?_i=AA",{"altText":343},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":355},"Wiltone Asuncion","wiltonetikr",[],[357],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":363,"date":364,"excerpt":365,"wordCount":366,"uri":367,"slug":368,"cloudinaryAssetId":369,"featuredImageOriginalUrl":370,"featuredImageMetadata":371,"author":372,"categories":374,"relatedPosts":376},"L'action de Tempus AI recule de 7 % malgré une croissance record des données : Pourquoi un carnet de commandes de 1,1 milliard de dollars garantit une cible de 112 dollars","2026-02-27 15:10:00","Les actions de Tempus AI (TEM) ont connu un récent recul après la publication de résultats hautement stratégiques au quatrième trimestre, qui ont confirmé la position dominante de l'entreprise dans le secteur de l'intelligence artificielle dans le domaine de la santé.",926,"\u002Fblog\u002Ftempus-ai-stock-pulls-back-7-despite-record-data-growth-why-a-1-1-billion-backlog-secures-a-112-target","tempus-ai-stock-pulls-back-7-despite-record-data-growth-why-a-1-1-billion-backlog-secures-a-112-target","images\u002F13-8\u002F13-8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772147820\u002Fimages\u002F13-8\u002F13-8.png?_i=AA",{"altText":363},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":373},[],[375],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":378,"date":379,"excerpt":380,"wordCount":381,"uri":382,"slug":383,"cloudinaryAssetId":384,"featuredImageOriginalUrl":385,"featuredImageMetadata":386,"author":387,"categories":389,"relatedPosts":391},"L'action United Therapeutics gagne 65% sur l'année écoulée : Pourquoi un record de 3 milliards de dollars garantit une cible de 687 dollars","2026-02-27 15:00:00","Les actions de United Therapeutics (UTHR) se maintiennent après que le leader de la médecine pulmonaire a présenté des résultats record pour 2025 et dévoilé un pipeline de lancements commerciaux massifs pour 2027.",866,"\u002Fblog\u002Funited-therapeutics-stock-gains-65-over-the-past-year-why-a-3-billion-record-secures-a-687-target","united-therapeutics-stock-gains-65-over-the-past-year-why-a-3-billion-record-secures-a-687-target","images\u002F12-9\u002F12-9","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772147806\u002Fimages\u002F12-9\u002F12-9.png?_i=AA",{"altText":378},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":388},[],[390],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":393,"date":394,"excerpt":395,"wordCount":396,"uri":397,"slug":398,"cloudinaryAssetId":399,"featuredImageOriginalUrl":400,"featuredImageMetadata":401,"author":402,"categories":404,"relatedPosts":406},"L'action de Jazz Pharmaceuticals bondit de 13 % grâce à une percée dans le domaine de l'oncologie : voici où l'action pourrait aller en 2026","2026-02-27 14:50:00","Les actions de Jazz Pharmaceuticals sont en train de faire une percée massive à la suite d'un quatrième trimestre record et d'un virage hautement stratégique vers les maladies rares. ",950,"\u002Fblog\u002Fjazz-pharmaceuticals-stock-surges-13-on-oncology-breakthrough-heres-where-the-stock-could-go-in-2026","jazz-pharmaceuticals-stock-surges-13-on-oncology-breakthrough-heres-where-the-stock-could-go-in-2026","images\u002F11-10\u002F11-10","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772147794\u002Fimages\u002F11-10\u002F11-10.png?_i=AA",{"altText":393},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":403},[],[405],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":408,"date":409,"excerpt":410,"wordCount":411,"uri":412,"slug":413,"cloudinaryAssetId":414,"featuredImageOriginalUrl":415,"featuredImageMetadata":416,"author":417,"categories":419,"relatedPosts":421},"L'action Oddity Tech lutte contre une baisse de 67 % en un an : Voici où l'action pourrait aller en 2026","2026-02-27 14:40:00","Les actions d'Oddity Tech (ODD) sont sous pression après que l'entreprise de technologie de beauté a suspendu ses prévisions pour l'ensemble de l'année en raison d'une perturbation algorithmique anormale avec un partenaire publicitaire majeur. ",968,"\u002Fblog\u002Foddity-tech-stock-battles-a-67-1-year-decline-heres-where-the-stock-could-go-in-2026","oddity-tech-stock-battles-a-67-1-year-decline-heres-where-the-stock-could-go-in-2026","images\u002F10-10\u002F10-10","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772147780\u002Fimages\u002F10-10\u002F10-10.png?_i=AA",{"altText":408},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":418},[],[420],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":423,"date":424,"excerpt":425,"wordCount":426,"uri":427,"slug":428,"cloudinaryAssetId":429,"featuredImageOriginalUrl":430,"featuredImageMetadata":431,"author":432,"categories":436,"relatedPosts":441},"L'action Block monte en flèche alors que Jack Dorsey annonce le licenciement de la moitié de l'entreprise","2026-02-27 10:48:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",685,"\u002Fblog\u002Fblock-nyse-xyz-stock-skyrockets-as-jack-dorsey-announces-layoffs-for-half-the-company","block-nyse-xyz-stock-skyrockets-as-jack-dorsey-announces-layoffs-for-half-the-company","images\u002FIONQ-stock-1\u002FIONQ-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772186273\u002Fimages\u002FIONQ-stock-1\u002FIONQ-stock-1.png?_i=AA",{"altText":423},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":435},"Aditya Raghunath","adityatikr",[],[437],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":255,"title":443,"date":444,"excerpt":445,"wordCount":446,"uri":447,"slug":448,"cloudinaryAssetId":449,"featuredImageOriginalUrl":450,"featuredImageMetadata":451,"author":452,"categories":454,"relatedPosts":456},"Le constructeur de Jeep Stellantis annonce une perte annuelle historique suite à des dépréciations massives de VE","2026-02-27 09:45:00","L'action Stellantis a bondi de 6 % malgré une perte record de 26 milliards de dollars due à des dépréciations d'EV, les résultats du second semestre montrant des progrès dans le redressement de l'Amérique du Nord.",690,"\u002Fblog\u002Fjeep-maker-stellantis-stla-stock-historic-annual-loss-following-massive-ev-write-downs","jeep-maker-stellantis-stla-stock-historic-annual-loss-following-massive-ev-write-downs","images\u002FSTLA-stock\u002FSTLA-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772126404\u002Fimages\u002FSTLA-stock\u002FSTLA-stock.png?_i=AA",{"altText":443},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":453},[],[455],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},[],{"id":255,"title":458,"date":459,"excerpt":460,"wordCount":461,"uri":462,"slug":463,"cloudinaryAssetId":464,"featuredImageOriginalUrl":465,"featuredImageMetadata":466,"author":467,"categories":469,"relatedPosts":471},"L'action de Trade Desk chute de 5 %, les perspectives médiocres pour le premier trimestre éclipsant les résultats positifs.","2026-02-26 17:20:00","L'action de Trade Desk a chuté en raison de la faiblesse des prévisions pour le premier trimestre, alors que les dépenses publicitaires pour les produits de consommation courante et l'automobile chutent. Le chiffre d'affaires a manqué de 1,5 % malgré une amélioration au quatrième trimestre et des investissements importants dans l'intelligence artificielle.",971,"\u002Fblog\u002Ftrade-desk-nasdaq-ttd-stock-plunges-16-as-soft-q1-outlook-overshadows-earnings-beat","trade-desk-nasdaq-ttd-stock-plunges-16-as-soft-q1-outlook-overshadows-earnings-beat","images\u002FTTD-stock_9460423db0\u002FTTD-stock_9460423db0","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772124281\u002Fimages\u002FTTD-stock_9460423db0\u002FTTD-stock_9460423db0.png?_i=AA",{"altText":458},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":468},[],[470],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},[],{"id":255,"title":473,"date":474,"excerpt":475,"wordCount":476,"uri":477,"slug":478,"cloudinaryAssetId":479,"featuredImageOriginalUrl":480,"featuredImageMetadata":481,"author":482,"categories":484,"relatedPosts":486},"L'action d'Axon Enterprise s'envole de 18 %, la croissance des logiciels d'IA dépassant les estimations de Wall Street","2026-02-26 17:15:00","L'action d'Axon Enterprise a bondi de 18% suite aux bons résultats du quatrième trimestre. Les réservations de logiciels d'IA atteignent 750 millions de dollars et l'entreprise prévoit une croissance de 27 à 30 % de son chiffre d'affaires en 2026.",728,"\u002Fblog\u002Faxon-enterprise-stock-skyrockets-18-as-ai-software-growth-crushes-wall-street-estimates","axon-enterprise-stock-skyrockets-18-as-ai-software-growth-crushes-wall-street-estimates","images\u002FAXOM-stock-1\u002FAXOM-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772121281\u002Fimages\u002FAXOM-stock-1\u002FAXOM-stock-1.png?_i=AA",{"altText":473},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":483},[],[485],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},[],{"id":255,"title":488,"date":474,"excerpt":489,"wordCount":490,"uri":491,"slug":492,"cloudinaryAssetId":493,"featuredImageOriginalUrl":494,"featuredImageMetadata":495,"author":496,"categories":498,"relatedPosts":500},"L'action Snowflake s'envole grâce à une hausse du chiffre d'affaires et à une croissance record du nombre de clients","L'action Snowflake a glissé de 2 % malgré la publication des estimations pour le quatrième trimestre et la signature d'un contrat record de 400 millions de dollars, alors que l'anxiété liée à l'IA pèse sur le sentiment du secteur des logiciels.",863,"\u002Fblog\u002Fsnowflake-nyse-snow-stock-ticks-higher-q4-revenue-beat-and-record-customer-growth","snowflake-nyse-snow-stock-ticks-higher-q4-revenue-beat-and-record-customer-growth","images\u002FCCC-stock-1-1\u002FCCC-stock-1-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772125251\u002Fimages\u002FCCC-stock-1-1\u002FCCC-stock-1-1.png?_i=AA",{"altText":488},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":497},[],[499],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},[]]